research
Oncodesign Precision Medicine and Navigo Proteins GmbH Sign a Strategic Collaboration Agreement for the Research and Development of New Systemic Radiotherapy Agents
DIJON, France, May 15, 2024–(BUSINESS WIRE)–Regulatory News: Oncodesign Precision Medicine (OPM) (ISIN: FR001400CM63; Mnemonic: ALOPM), a biopharmaceutical company specializing in precision medicine for the treatment of resistant and metastatic cancers, and Navigo Proteins GmbH (Halle, Germany), a biopharmaceutical company specializing in the discovery and development of Precision Medicine applications based on the Affilin® technology platform, […]
Info-Tech Research Group Publishes Framework for Better Outcomes In Healthcare
Info-Tech Research Group’s latest industry research outlines the revolutionary potential of AI to personalize healthcare and offers key strategies for integrating AI-powered precision medicine into healthcare systems. The newly published blueprint provides actionable insights that enable healthcare organizations to enhance patient care and diagnostic accuracy through advanced AI applications, thereby improving treatment outcomes in the […]
UK research project gains EPSCR grant for medicine development
The research team will employ computer simulations and experiments to allow companies to design and test IR tablets virtually. Credit: De Montfort University. A collaborative research project between De Montfort University Leicester (DMU) and the University of Surrey in the UK has received a grant to help streamline and reduce costs for pharmaceutical companies in […]
Icahn School of Medicine at Mount Sinai Names Miriam Merad, MD, PhD, as Dean for Translational Research and Therapeutic Innovation
Newswise — New York, NY [April 29, 2024]—Miriam Merad, MD, PhD, a world-renowned immunologist, has been appointed Dean for Translational Research and Therapeutic Innovation of the Icahn School of Medicine at Mount Sinai. The appointment reaffirms Icahn Mount Sinai’s commitment to pioneering medical progress and catalyzing the rapid advancement of research innovation. Dr. Merad, the […]
Atossa Therapeutics Announces Expanded Research Agreement
SEATTLE, April 29, 2024 (GLOBE NEWSWIRE) — Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”) today announced an expanded research agreement with Weill Cornell Medicine to explore the potential synergy between antibody drugs conjugates (ADCs) and (Z)-endoxifen. Atossa is a clinical stage biopharmaceutical company developing innovative medicines in areas of significant unmet medical need […]